Tron’s Price Surge: Can It Sustain the Momentum? The Rise of Tron (TRX) Tron’s (TRX) price has hit a new 52-week high, signaling a strong bull run that many believe could push the altcoin toward $0.2621. However, recent market pullbacks and technical patterns are raising questions about whether the bullish momentum can continue in the…
Immutep Limited Announces Positive Data from INSIGHT-003 Trial Mature Data Shows Excellent Results in NSCLC Patients Sydney, Australia, Nov. 14, 2024 (GLOBE NEWSWIRE) – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company, has released positive data from the INSIGHT-003 Phase I trial. Immutep’s latest data from patients with a…
Breaking News: Birchtech’s Third Quarter 2024 Financial Report Unveiled! Corsicana, Texas–(Newsfile Corp. – November 14, 2024) – 8:07 AM ET Birchtech Corp. (TSX: BCHT) (OTCQB: BCHT) (“Birchtech” or the “Company”), a leading environmental technologies firm, has reported financial results for the third quarter ended September 30, 2024. The Company reports the following highlights for the…
Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence package for imminent submission to formally seek Medicare coverage Veris Health completes pilot program with The Ohio State’s James Cancer Hospital and continues pursuit of financing to relaunch development of implantable monitor Ongoing initiatives position PAVmed to preserve Nasdaq listing NEW YORK, Nov. 14, 2024…
Akebia Therapeutics Publishes Important Results of FO2CUS Trial on Vafseo® Continuing to Revolutionize Treatment for Kidney Disease It’s always exciting to see groundbreaking advancements in the field of medicine, especially when it comes to treating serious conditions like kidney disease. Akebia Therapeutics®, Inc., a leading biopharmaceutical company, has been at the forefront of innovation in…
Near-Term Revenue Potential with Commercialization Plan for FDA-Cleared RenovoCath® Delivery System Renowned Clinical Oncology Sites Participating in Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial Trial Moving Towards Next Interim Analysis and Full Enrollment As of September 30, 2024, the Company had $9.6 million in Cash, Sufficient to Fund Operations to Achieve Next Interim Read-Out and…
Rising Above Uncertainty: HSBC’s Global Entrepreneurial Wealth Report Shows U.S. Entrepreneurs Remain Resilient and Optimistic Embracing a Positive Outlook Revealing Insights HSBC’s Global Entrepreneurial Wealth Report 2024 has shed light on the mindset of U.S. entrepreneurs in the face of uncertainties within the global markets. The report showcases that an impressive 94% of High Net…
United Airlines Continues to Soar in 3Q24 Financial Performance In the third quarter of 2024, United Airlines reported impressive financial results with revenues reaching $14.85 billion, marking a 2.48% year-on-year growth. While the earnings per share (EPS) of $3.33 surpassed expectations, the net income experienced a decline of 15.13% compared to the previous year. Despite…
